BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20210737)

  • 1. Non-denaturing solubilization of inclusion bodies.
    Tsumoto K; Abe R; Ejima D; Arakawa T
    Curr Pharm Biotechnol; 2010 Apr; 11(3):309-12. PubMed ID: 20210737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization of active green fluorescent protein from insoluble particles by guanidine and arginine.
    Tsumoto K; Umetsu M; Kumagai I; Ejima D; Arakawa T
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1383-6. PubMed ID: 14652027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Techno-economic evaluation of an inclusion body solubilization and recombinant protein refolding process.
    Freydell EJ; van der Wielen LA; Eppink MH; Ottens M
    Biotechnol Prog; 2011; 27(5):1315-28. PubMed ID: 21674819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of high pressure and alkaline condition for solubilization of inclusion bodies and refolding of the NS1 protein from zika virus.
    Rosa da Silva CM; Chura-Chambi RM; Ramos Pereira L; Cordeiro Y; de Souza Ferreira LC; Morganti L
    BMC Biotechnol; 2018 Dec; 18(1):78. PubMed ID: 30541520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of solutes on solubilization and refolding of proteins from inclusion bodies with high hydrostatic pressure.
    Lee SH; Carpenter JF; Chang BS; Randolph TW; Kim YS
    Protein Sci; 2006 Feb; 15(2):304-13. PubMed ID: 16385003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient solubilization of inclusion bodies.
    Freydell EJ; Ottens M; Eppink M; van Dedem G; van der Wielen L
    Biotechnol J; 2007 Jun; 2(6):678-84. PubMed ID: 17492713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study to develop a single method for retrieving wide class of recombinant proteins from classical inclusion bodies.
    Padhiar AA; Chanda W; Joseph TP; Guo X; Liu M; Sha L; Batool S; Gao Y; Zhang W; Huang M; Zhong M
    Appl Microbiol Biotechnol; 2018 Mar; 102(5):2363-2377. PubMed ID: 29387954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent.
    Upadhyay V; Singh A; Jha D; Singh A; Panda AK
    Microb Cell Fact; 2016 Jun; 15():100. PubMed ID: 27277580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process.
    Sarker A; Rathore AS; Gupta RD
    Microb Cell Fact; 2019 Jan; 18(1):5. PubMed ID: 30642336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of arginine in protein refolding, solubilization, and purification.
    Tsumoto K; Umetsu M; Kumagai I; Ejima D; Philo JS; Arakawa T
    Biotechnol Prog; 2004; 20(5):1301-8. PubMed ID: 15458311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human growth hormone inclusion bodies present native-like secondary and tertiary structures which can be preserved by mild solubilization for refolding.
    Chura-Chambi RM; Farah CS; Morganti L
    Microb Cell Fact; 2022 Aug; 21(1):164. PubMed ID: 35978337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
    Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
    Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refolding of alpha 1-antitrypsin expressed as inclusion bodies in Escherichia coli: characterization of aggregation.
    Kwon KS; Lee S; Yu MH
    Biochim Biophys Acta; 1995 Mar; 1247(2):179-84. PubMed ID: 7696306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of inclusion bodies using PEG precipitation under denaturing conditions to produce recombinant therapeutic proteins from Escherichia coli.
    Chen H; Li N; Xie Y; Jiang H; Yang X; Cagliero C; Shi S; Zhu C; Luo H; Chen J; Zhang L; Zhao M; Feng L; Lu H; Zhu J
    Appl Microbiol Biotechnol; 2017 Jul; 101(13):5267-5278. PubMed ID: 28391504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test bacterial inclusion body for activity prior to start denaturing and refolding processes to obtain active eukaryotic proteins.
    Hamidi SR; Safdari Y; Sheikh Arabi M
    Protein Expr Purif; 2019 Feb; 154():147-151. PubMed ID: 30389592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refolding solubilized inclusion body proteins.
    Burgess RR
    Methods Enzymol; 2009; 463():259-82. PubMed ID: 19892177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process.
    Singh A; Upadhyay V; Upadhyay AK; Singh SM; Panda AK
    Microb Cell Fact; 2015 Mar; 14():41. PubMed ID: 25889252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient solubilization and purification of highly insoluble membrane proteins expressed as inclusion bodies using perfluorooctanoic acid.
    Plucinsky SM; Root KT; Glover KJ
    Protein Expr Purif; 2018 Mar; 143():34-37. PubMed ID: 29066155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality comparison of recombinant soluble proteins and proteins solubilized from bacterial inclusion bodies.
    López-Cano A; Sicilia P; Gaja C; Arís A; Garcia-Fruitós E
    N Biotechnol; 2022 Dec; 72():58-63. PubMed ID: 36150649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and expression of phosphoenolpyruvate carboxykinase from a cestode parasite and its solubilization from inclusion bodies using l-arginine.
    Dutta AK; Ramnath ; Dkhar B; Tandon V; Das B
    Protein Expr Purif; 2016 Sep; 125():61-7. PubMed ID: 26363119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.